Document is current
Any future updates will be listed below
-
Authors
Schlosser, Marco
Gonneaud, Julie
Poletti, Stefano
Bouet, Romain
Klimecki, Olga M.
Collette, Fabienne
Marchant, Natalie L.
Chételat, Gaël
Lutz, Antoine
,
André, Claire
Allais, Florence
Asselineau, Julien
Arenaza-Urquijo, Eider
Baez, Sebastian
Batchelor, Martine
Beaugonin, Axel
Botton, Maelle
Champetier, Pierre
Chocat, Anne
Delamillieure, Pascal
De La Sayette, Vincent
Delarue, Marion
Demnitz-King, Harriet
Dolma, Titi
Egret, Stéphanie
Felisatti, Francesca
Ferrand-Devouges, Eglantine
Frison, Eric
Gheysen, Francis
Philippe, Agathe Joret
Kuhn, Elizabeth
Landeau, Brigitte
Ledu, Gwendoline
Lefranc, Valérie
Mezenge, Florence
Moulinet, Inès
Ourry, Valentin
Palix, Cassandre
Paly, Léo
Poisnel, Géraldine
Quillard, Anne
Rauchs, Géraldine
Requier, Florence
Salmon, Eric
Schwimmer, Corrine
Touron, Edelweiss
Ware, Caitlin
Whitfield, Tim
-
Funding
Funding for this research was provided by:
Horizon 2020 Framework Programme (667696, 667696, 667696, 667696, 667696, 667696)
- License Information
-
More Information
Article History
Received: 7 March 2024
Accepted: 18 October 2024
First Online: 2 November 2024
Declarations
:
: GC, FC, OMK, AL, and NLM have received research support from the EU’s Horizon 2020 research and innovation programme (grant agreement number 667696). GC has received research support from Inserm, Fondation d’entreprise MMA des Entrepreneurs du Futur, Fondation Alzheimer, Programme Hospitalier de Recherche Clinique, Région Normandie, Association France Alzheimer et maladies apparentées and Fondation Vaincre Alzheimer (all to Inserm), GC and AL have received research support and personal fees from Fondation d’entreprise MMA des Entrepreneurs du Futur. All other authors have declared that no competing interests exist.
